
Emily
Gee
Vice President and Coordinator for Health Policy
We advance health coverage, health care access and affordability, public health and equity, and quality and efficiency in health care payment and delivery.
We are dedicated to bolstering affordable, high-quality health coverage options. By building on the Affordable Care Act, closing the Medicaid coverage gap, and developing progressive solutions for a world in which everyone can access care.
We are working to advance health in all communities and reduce health inequities that foster disparate outcomes. This includes addressing the significant vulnerabilities in our public health system to ensure that it is more resilient and ready to respond to the COVID-19 pandemic and future health threats.
We are finding ways to reduce costs while improving health care quality and addressing the social and economic factors that influence health. Via delivery system and payment reform, the government has ample opportunities to bolster efficiency and quality in health care.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The federal government can make it easier and more affordable for individuals to reduce their own COVID-19 risk and take action to support public health.
Emily Gee writes about how public transit can expand access to health care.
Jill Rosenthal outlines next steps that the Biden administration, state and local policymakers, and private companies should take to prevent a winter surge in COVID-19 cases.
The House-passed bill expands insurance coverage, reduces prescription drug costs, and makes crucial investments in maternal and public health.
Jill Rosenthal discusses the efficacy of COVID-19 vaccine mandates.
To meaningfully improve the health of Americans, new policies must target all of the drivers of health, including education, economic stability, neighborhoods and environments, social and community well-being, and historic inequities.
By addressing key priorities, the budget reconciliation process can advance health and economic recovery and deliver benefits to the individuals, neighborhoods, and communities that need them the most.
Reducing prescription drug prices does not have to come at the price of pharmaceutical innovation.
New poverty, income, and health insurance data confirm that poverty is a policy choice.
Value-based pricing aligns prescription drug prices to their clinical benefits, leading to lower spending and better health outcomes.